Janus Henderson Group PLC 4 D Molecular Therapeutics, Inc. Transaction History

Janus Henderson Group PLC

$187 Billion
Q3 2024

A detailed history of Janus Henderson Group PLC transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 3,137,087 shares of FDMT stock, worth $17.5 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,137,087

Previous 3,196,762 1.87%

Holding current value

$17.5 Million

Previous $67.1 Million 49.46%

% of portfolio

0.02%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$10.81 - $27.22 $645,086 - $1.62 Million	-59,675 Reduced 1.87%	3,137,087 $33.9 Million
Q2 2024 Aug 14, 2024	SELL	$20.93 - $30.01 $14,274 - $20,466	-682 Reduced 0.02%	3,196,762 $67.1 Million
Q1 2024 May 15, 2024	BUY	$17.03 - $35.87 $1.77 Million - $3.74 Million	104,148 Added 3.37%	3,197,444 $102 Million
Q4 2023 Feb 14, 2024	BUY	$9.76 - $21.25 $3.39 Million - $7.37 Million	346,961 Added 12.63%	3,093,296 $62.7 Million
Q3 2023 Nov 14, 2023	SELL	$12.64 - $19.76 $1.17 Million - $1.83 Million	-92,547 Reduced 3.26%	2,746,335 $35 Million
Q2 2023 Aug 14, 2023	BUY	$15.16 - $23.26 $14.6 Million - $22.4 Million	961,457 Added 51.21%	2,838,882 $51.3 Million
Q1 2023 May 15, 2023	BUY	$15.45 - $23.19 $6.35 Million - $9.53 Million	411,158 Added 28.04%	1,877,425 $32.3 Million
Q4 2022 Feb 14, 2023	BUY	$6.85 - $25.46 $1 Million - $3.73 Million	146,536 Added 11.1%	1,466,267 $32.6 Million
Q3 2022 Nov 14, 2022	SELL	$6.96 - $11.48 $106,606 - $175,839	-15,317 Reduced 1.15%	1,319,731 $10.6 Million
Q2 2022 Aug 15, 2022	SELL	$5.68 - $15.99 $1.88 Million - $5.28 Million	-330,363 Reduced 19.84%	1,335,048 $9.32 Million
Q1 2022 May 16, 2022	BUY	$13.16 - $22.64 $230,142 - $395,928	17,488 Added 1.06%	1,665,411 $25.2 Million
Q4 2021 Feb 14, 2022	BUY	$19.56 - $32.94 $2.48 Million - $4.18 Million	126,820 Added 8.34%	1,647,923 $36.2 Million
Q3 2021 Nov 16, 2021	SELL	$22.73 - $36.04 $423,300 - $671,172	-18,623 Reduced 1.21%	1,521,103 $41 Million
Q2 2021 Aug 16, 2021	BUY	$22.2 - $42.29 $6.93 Million - $13.2 Million	312,329 Added 25.45%	1,539,726 $37.1 Million
Q1 2021 May 17, 2021	BUY	$35.94 - $52.67 $7.39 Million - $10.8 Million	205,486 Added 20.11%	1,227,397 $50.7 Million
Q4 2020 Feb 16, 2021	BUY	$38.43 - $47.36 $39.3 Million - $48.4 Million	1,021,911 New	1,021,911 $39.9 Million

Others Institutions Holding FDMT

# of Institutions

144

Shares Held

57.7M

Call Options Held

137K

Put Options Held

111K

View Full List

About 4D Molecular Therapeutics, Inc.

Ticker FDMT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,382,400
Market Cap $180M
Description
4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...

More about FDMT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC 4 D Molecular Therapeutics, Inc. Transaction History